Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.

Herbaux C, Bret C, Bachy E, Bories P, Di Blasi R, Cuffel A, Gastinne T, Lamy T, Roussel M, Bouabdallah K, Beauvais D, Cartron G, Bay JO, Blaise D, Rubio MT, Mohty M, Le Bras F, Casasnovas O, Guy J, Guidez S, Llorente CC, Hermine O, La Rochelle LD, Carras S, Guffroy B, Caillat-Zucman S, Houot R, Le Gouill S

Open source

DOI: 10.3324/haematol.2023.284786
Published: 2024 Nov 1
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2023.284786,
  title = {Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.},
  author = {Herbaux C and Bret C and Bachy E and Bories P and Di Blasi R and Cuffel A and Gastinne T and Lamy T and Roussel M and Bouabdallah K and Beauvais D and Cartron G and Bay JO and Blaise D and Rubio MT and Mohty M and Le Bras F and Casasnovas O and Guy J and Guidez S and Llorente CC and Hermine O and La Rochelle LD and Carras S and Guffroy B and Caillat-Zucman S and Houot R and Le Gouill S},
  year = {2024},
  journal = {Haematologica},
  doi = {10.3324/haematol.2023.284786},
  url = {https://doi.org/10.3324/haematol.2023.284786}
}

RIS

TY  - JOUR
TI  - Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.
AU  - Herbaux C
AU  - Bret C
AU  - Bachy E
AU  - Bories P
AU  - Di Blasi R
AU  - Cuffel A
AU  - Gastinne T
AU  - Lamy T
AU  - Roussel M
AU  - Bouabdallah K
AU  - Beauvais D
AU  - Cartron G
AU  - Bay JO
AU  - Blaise D
AU  - Rubio MT
AU  - Mohty M
AU  - Le Bras F
AU  - Casasnovas O
AU  - Guy J
AU  - Guidez S
AU  - Llorente CC
AU  - Hermine O
AU  - La Rochelle LD
AU  - Carras S
AU  - Guffroy B
AU  - Caillat-Zucman S
AU  - Houot R
AU  - Le Gouill S
PY  - 2024
JO  - Haematologica
DO  - 10.3324/haematol.2023.284786
UR  - https://doi.org/10.3324/haematol.2023.284786
ER  -

APA

C, H., C, B., E, B., P, B., R, D. B., A, C., T, G., T, L., M, R., K, B., D, B., G, C., JO, B., D, B., MT, R., M, M., F, L. B., O, C., J, G., S, G., CC, L., O, H., LD, L. R., S, C., B, G., S, C., R, H., & S, L. G. (2024). Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.. Haematologica. https://doi.org/10.3324/haematol.2023.284786

Source records

pubmed · retrieved 2026-09-26T20:23:56.448Z